← FDA Drug Approvals (Drugs@FDA)
ABACAVIR SULFATE AND LAMIVUDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2018-11-15
Drug application
- FDA Application #
ANDA208990- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ABACAVIR SULFATE AND LAMIVUDINE
- Generic name
- Abacavir Sulfate
- Active ingredients
- ABACAVIR SULFATE; LAMIVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ZYDUS PHARMS
- First approval
- 2018-11-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown